Non-interventional Study of Patients Using Norditropin® for Growth Hormone Deficiency or Turner Syndrome

CompletedOBSERVATIONAL
Enrollment

2,016

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Growth Hormone DisorderGrowth Hormone Deficiency in ChildrenGenetic DisorderTurner Syndrome
Interventions
DRUG

somatropin

Collection of safety and efficacy data in connection with use of somatropin (Norditropin®) in daily clinical practice.

Trial Locations (1)

1000005

Tokyo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY